The size of NBC’s broadcasting team for its PGA Tour coverage has been reduced to about the size of a 1-iron.
Its latest change includes Kathryn Tappen, who handled post-round interviews this season, being out, sources confirmed to The Post. The Quadrilateral newsletter was first to report the news.Dave Sandford/NHLI via Getty Images
, took over for Steve Sands as the network’s lead interview after Sands was promoted to an anchor role. Per Golfweek, Tappen is in talks for a bigger role within NBC and has also drawn interest from TNT and ESPN.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
N.J. native, Rutgers alum Kathryn Tappen changing job again, could leave NBC Sports, report saysKathryn Tappen had been in line for the sideline reporter gig on Sunday Night Football until NBC Sports stunned by hiring Melissa Stark to replace Michele Tafoya.
Lire la suite »
She Put Her Own Spin on a Classic PorscheNetflix executive Kathryn Koehler got her 1972 Porsche 911E at 16, and learned to drive it on a racetrack
Lire la suite »
14-year-old girl reported missing in San DiegoKathryn Wallake is white, 5 feet, 3 inches tall, weighs 130 pounds and was last seen wearing a black hooded sweatshirt with white skulls, brown leggings and black high-top Converse shoes.
Lire la suite »
Agatha: Coven of Chaos: Everything We Know So Far About the WandaVision Spinoff - E! OnlineKathryn Hahn is headed back to Disney+ on the upcoming WandaVision spinoff series Agatha: Coven of Chaos. Find out everything we know so far, from the cast to the premiere date and more.
Lire la suite »
North New Braunfels Phase 1 Project impacts neighborhood, residents want progressThe North New Braunfels Phase 1 Project on the East Side promises to improve bridges, sidewalks and streets, but people are ready to see that promise fulfilled.
Lire la suite »
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial - Nature MedicineIn a prespecified interim analysis of a pivotal phase 2 trial, tisagenlecleucel, an autologous CD19-targeting CAR-T cell therapy, produced a high rate of complete responses with a manageable safety profile in adults with relapsed or refractory follicular lymphoma
Lire la suite »